- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
-
- 长期趋势：
已有186家主力机构披露2024-06-30报告期持股数据，持仓量总计4.04亿股，占流通A股84.56%
- 波段诊断：
-
技术面诊股
诊断结果：3.4技术面打败了74%的股票
技术面评分前10的股票
近期的平均成本为30.18元。
平均成本
近期的平均成本为30.18元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"30.18","date":1732175416,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2024.11.22","stock":"-5.24","trade":"-4.07","ind":"-3.52"},{"date":"2024.11.21","stock":"-0.89","trade":"-0.18","ind":"-0.07"},{"date":"2024.11.20","stock":"0.83","trade":"2.34","ind":"0.78"},{"date":"2024.11.19","stock":"-1.58","trade":"0.64","ind":"1.90"},{"date":"2024.11.18","stock":"3.87","trade":"-0.65","ind":"-1.91"},{"date":"2024.11.15","stock":"-2.03","trade":"-2.29","ind":"-2.62"},{"date":"2024.11.14","stock":"-1.71","trade":"-3.87","ind":"-2.83"},{"date":"2024.11.13","stock":"-1.68","trade":"-1.73","ind":"0.40"},{"date":"2024.11.12","stock":"7.63","trade":"5.16","ind":"-0.65"},{"date":"2024.11.11","stock":"0.10","trade":"0.99","ind":"2.03"},{"date":"2024.11.08","stock":"-1.26","trade":"-1.13","ind":"-0.66"},{"date":"2024.11.07","stock":"1.68","trade":"2.85","ind":"2.44"},{"date":"2024.11.06","stock":"-0.57","trade":"0.28","ind":"-0.35"},{"date":"2024.11.05","stock":"3.39","trade":"1.11","ind":"3.22"},{"date":"2024.11.04","stock":"1.01","trade":"2.16","ind":"1.99"},{"date":"2024.11.01","stock":"2.84","trade":"3.44","ind":"-1.28"},{"date":"2024.10.31","stock":"-0.07","trade":"0.60","ind":"0.57"},{"date":"2024.10.30","stock":"-0.99","trade":"-0.40","ind":"-0.12"},{"date":"2024.10.29","stock":"-3.06","trade":"-2.99","ind":"-1.33"},{"date":"2024.10.28","stock":"1.22","trade":"2.25","ind":"0.62"},{"date":"2024.10.25","stock":"0.99","trade":"1.75","ind":"1.71"}]
国药一致,深证成指,医药商业指数
压力支撑
该股压力位为30.16元，支撑位为29.11元。
[{"text":"\u538b\u529b\u4f4d","value":"30.16","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"29.11","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.2资金面打败了13%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月22日 17:10
| 机构今日流向(万元) | -3793.62 | 机构5日流向(万元) | -5417.89 |
| 机构10日流向(万元) | -20931.08 | 机构20日流向(万元) | -32398.34 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加3133.46万股，其中基金净减仓19家，主力净增仓21家，请投资者中长期谨慎为宜。
截止2024-06-30，共186家主力机构（基金180家，一般法人4家，社保基金2家），持仓量总计40423.69万股，占流通A股84.56%
其中，基金持仓与2023-12-31相比：
增仓：25家 ，增持 1063.33万股
减仓：44家 ，减持 332.34万股
新出现在主力名单中：100家 ，持有3133.43万股
从主力名单中消失：79家 ，原持有698.35万股
其中，基金持仓与2023-12-31相比：
增仓：25家 ，增持 1063.33万股
减仓：44家 ，减持 332.34万股
新出现在主力名单中：100家 ，持有3133.43万股
从主力名单中消失：79家 ，原持有698.35万股
消息面诊股
诊断结果：5.5消息面打败了4%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 国药一致：11月21日融券卖出金额3113.00元
2024-11-22 - 国药一致：11月19日获融资买入2544.33万元
2024-11-20 - 国药一致两位董事辞职
2024-11-19 - 国药一致：11月18日获融资买入3169.72万元
2024-11-19 - 国药一致：公司董事刘勇和李晓娟辞任
2024-11-18 - 券商观点|医药行业周报：创新药加速出海，全球化趋势
2024-11-18 - 大事件！涉及并购重组 16只潜力股出炉
2024-11-18 - 不少上市药企困在应收账款里，上海医药高达831亿元
2024-11-14 - 国药一致：11月13日融券卖出金额55.69万元，
2024-11-14 - 国药一致：11月12日获融资买入5642.60万元
2024-11-13
消息列表
| 一般消息 | 高管变动 | 因工作调整 | 2024-11-18 |
| 一般消息 | 高管变动 | 因达到法定退休年龄 | 2024-10-08 |
| 一般消息 | 高管变动 | 因达到法定退休年龄 | 2024-09-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-29 |
| 一般消息 | 股东大会 | 临时股东大会 | 2024-06-20 |
| 一般消息 | 重大事项 | 关联交易 | 2024-05-09 |
| 一般消息 | 高管变动 | 不再担任 | 2024-05-08 |
| 一般消息 | 高管变动 | 因工作调整 | 2024-04-11 |
| 利好 | 分红转增 | 10派6.8元(含税) | 2024-04-08 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-08 |
| 一般消息 | 高管变动 | 公司内部工作调整 | 2024-02-02 |
| 一般消息 | 高管变动 | 工作调整原因 | 2024-01-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了83%的股票
医药商业行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2024.11.22","price":"-3.52","value":"-4.07"},{"date":"2024.11.21","price":"-0.07","value":"-0.18"},{"date":"2024.11.20","price":"0.78","value":"2.34"},{"date":"2024.11.19","price":"1.90","value":"0.64"},{"date":"2024.11.18","price":"-1.91","value":"-0.65"},{"date":"2024.11.15","price":"-2.62","value":"-2.29"},{"date":"2024.11.14","price":"-2.83","value":"-3.87"},{"date":"2024.11.13","price":"0.40","value":"-1.73"},{"date":"2024.11.12","price":"-0.65","value":"5.16"},{"date":"2024.11.11","price":"2.03","value":"0.99"},{"date":"2024.11.08","price":"-0.66","value":"-1.13"},{"date":"2024.11.07","price":"2.44","value":"2.85"},{"date":"2024.11.06","price":"-0.35","value":"0.28"},{"date":"2024.11.05","price":"3.22","value":"1.11"},{"date":"2024.11.04","price":"1.99","value":"2.16"},{"date":"2024.11.01","price":"-1.28","value":"3.44"},{"date":"2024.10.31","price":"0.57","value":"0.60"},{"date":"2024.10.30","price":"-0.12","value":"-0.40"},{"date":"2024.10.29","price":"-1.33","value":"-2.99"},{"date":"2024.10.28","price":"0.62","value":"2.25"},{"date":"2024.10.25","price":"1.71","value":"1.75"}]
深证成指,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 健之佳 | 18.88% | 3.73% | 5.0分 |
| 2 | 药易购 | 14.73% | -12.70% | 3.9分 |
| 3 | 塞力医疗 | 13.09% | 0.00% | 4.2分 |
| 4 | 漱玉平民 | 11.73% | -3.61% | 3.8分 |
| 5 | 国药股份 | 10.41% | 2.16% | 5.1分 |
| 6 | 人民同泰 | 10.40% | -2.54% | 4.5分 |
| 8 | 第一医药 | 9.64% | -4.77% | 4.1分 |
| 10 | 嘉事堂 | 6.74% | 2.94% | 4.3分 |
| 12 | 老百姓 | 4.14% | -2.87% | 4.7分 |
| 14 | 上海医药 | 3.68% | 5.34% | 5.7分 |
| 16 | 柳药集团 | 3.39% | 0.33% | 4.6分 |
| 18 | 大参林 | 2.34% | -4.49% | 4.8分 |
| 20 | 合富中国 | 1.45% | -3.85% | 3.8分 |
| 22 | 瑞康医药 | 0.96% | 1.95% | 3.9分 |
| 24 | 浙江震元 | -1.10% | -0.25% | 4.2分 |
| 26 | 一心堂 | -2.09% | -4.57% | 3.9分 |
| 28 | 开开实业 | -6.34% | -5.25% | 4.0分 |
| 30 | 达嘉维康 | -8.86% | -2.10% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 13/71 ， 19/71。
[{"date":"2024-09-30","value":"6.00","vol":"5.85"},{"date":"2024-06-30","value":"4.22","vol":"4.44"},{"date":"2024-03-31","value":"2.21","vol":"2.30"},{"date":"2023-12-31","value":"9.54","vol":"7.23"},{"date":"2023-09-30","value":"7.19","vol":"7.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.00 | 4.22 | 2.21 | 9.54 | 7.19 |
| 行业(%) | 5.85 | 4.44 | 2.30 | 7.23 | 7.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"10.87","vol":"17.89"},{"date":"2024-06-30","value":"10.96","vol":"17.84"},{"date":"2024-03-31","value":"10.86","vol":"17.80"},{"date":"2023-12-31","value":"11.99","vol":"17.83"},{"date":"2023-09-30","value":"11.56","vol":"18.09"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
10.87 | 10.96 | 10.86 | 11.99 | 11.56 |
| 行业(%) | 17.89 | 17.84 | 17.80 | 17.83 | 18.09 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/71 ， 17/71。
[{"date":"2024-09-30","value":"-0.21","vol":"2.06"},{"date":"2024-06-30","value":"-1.57","vol":"1.88"},{"date":"2024-03-31","value":"2.16","vol":"4.80"},{"date":"2023-12-31","value":"2.77","vol":"4.27"},{"date":"2023-09-30","value":"3.61","vol":"6.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.21 | -1.57 | 2.16 | 2.77 | 3.61 |
| 行业(%) | 2.06 | 1.88 | 4.80 | 4.27 | 6.21 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-10.43","vol":"-50.40"},{"date":"2024-06-30","value":"-10.45","vol":"-17.67"},{"date":"2024-03-31","value":"7.33","vol":"3.54"},{"date":"2023-12-31","value":"7.57","vol":"2.19"},{"date":"2023-09-30","value":"13.56","vol":"10.40"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-10.43 | -10.45 | 7.33 | 7.57 | 13.56 |
| 行业(%) | -50.40 | -17.67 | 3.54 | 2.19 | 10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/71 ， 8/71。
[{"date":"2024-09-30","value":"1.13","vol":"0.89"},{"date":"2024-06-30","value":"0.76","vol":"0.60"},{"date":"2024-03-31","value":"0.39","vol":"0.31"},{"date":"2023-12-31","value":"1.67","vol":"1.24"},{"date":"2023-09-30","value":"1.21","vol":"0.91"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
1.13 | 0.76 | 0.39 | 1.67 | 1.21 |
| 行业(次) | 0.89 | 0.60 | 0.31 | 1.24 | 0.91 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"6.14","vol":"4.52"},{"date":"2024-06-30","value":"4.11","vol":"3.08"},{"date":"2024-03-31","value":"2.10","vol":"1.58"},{"date":"2023-12-31","value":"8.39","vol":"6.32"},{"date":"2023-09-30","value":"6.13","vol":"4.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
6.14 | 4.11 | 2.10 | 8.39 | 6.13 |
| 行业(次) | 4.52 | 3.08 | 1.58 | 6.32 | 4.72 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"1.88","vol":"4.01"},{"date":"2024-06-30","value":"8.36","vol":"6.46"},{"date":"2024-03-31","value":"-3.32","vol":"-3.83"},{"date":"2023-12-31","value":"7.79","vol":"10.23"},{"date":"2023-09-30","value":"-0.11","vol":"2.62"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 1.88 | 8.36 | -3.32 | 7.79 | -0.11 |
| 行业 | 4.01 | 6.46 | -3.83 | 10.23 | 2.62 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.16","vol":"0.77"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.20","vol":"1.02"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.16 | - | 0.20 | - |
| 行业 | 0.00 | 0.77 | 0.00 | 1.02 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 12/71 ， 11/71。
[{"date":"2024-09-30","value":"1.45","vol":"1.47"},{"date":"2024-06-30","value":"1.44","vol":"1.49"},{"date":"2024-03-31","value":"1.45","vol":"1.51"},{"date":"2023-12-31","value":"1.49","vol":"1.51"},{"date":"2023-09-30","value":"1.41","vol":"1.48"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.45 | 1.44 | 1.45 | 1.49 | 1.41 |
| 行业 | 1.47 | 1.49 | 1.51 | 1.51 | 1.48 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.12","vol":"1.04"},{"date":"2024-06-30","value":"1.11","vol":"1.06"},{"date":"2024-03-31","value":"1.12","vol":"1.09"},{"date":"2023-12-31","value":"1.13","vol":"1.07"},{"date":"2023-09-30","value":"1.09","vol":"1.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.12 | 1.11 | 1.12 | 1.13 | 1.09 |
| 行业 | 1.04 | 1.06 | 1.09 | 1.07 | 1.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 6/71 ， 21/71。
[{"date":"2024-09-30","value":"58.34","vol":"61.64"},{"date":"2024-06-30","value":"58.47","vol":"61.18"},{"date":"2024-03-31","value":"58.43","vol":"61.00"},{"date":"2023-12-31","value":"55.90","vol":"60.66"},{"date":"2023-09-30","value":"59.66","vol":"61.05"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
58.34 | 58.47 | 58.43 | 55.90 | 59.66 |
| 行业(%) | 61.64 | 61.18 | 61.00 | 60.66 | 61.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.68","vol":"2.19"},{"date":"2024-06-30","value":"1.69","vol":"2.15"},{"date":"2024-03-31","value":"1.69","vol":"2.15"},{"date":"2023-12-31","value":"1.53","vol":"2.12"},{"date":"2023-09-30","value":"1.78","vol":"2.07"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.68 | 1.69 | 1.69 | 1.53 | 1.78 |
| 行业(%) | 2.19 | 2.15 | 2.15 | 2.12 | 2.07 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投证券 | 2024-11-07 | 买入 | 买入 |
| 国泰君安 | 2024-11-03 | 买入 | 买入 |
| 华源证券 | 2024-10-30 | 买入 | 买入 |
| 华泰金融(HK) | 2024-10-30 | 买入 | 买入 |
| 华泰证券 | 2024-10-29 | 买入 | 买入 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"14.02","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"13.36","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"14.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"15.99","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"14.40","blueLineValue":"2.59","type":"YC"}]